共 87 条
[1]
Horodinschi RN(2019)Treatment with statins in elderly patients Medicina 55 2-11
[2]
Alexandra Stanescu AM(2016)2016 ESC/EAS Guidelines for the management of dyslipidaemias Eur Heart J 37 2999-3058
[3]
Gabriel Bratu O(2007)Is it time for a cardiovascular primary prevention trial in the elderly? Stroke 38 441-50
[4]
Stoian AP(2019)2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk Eur Heart J 41 1-78
[5]
Radavoi DJ(2002)Resource management in prevention of coronary heart disease: optimising prescription of lipid-lowering drugs Lancet 359 2271-3
[6]
Diaconu CC(2018)2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines J Am Coll Cardiol. 73 e285-e350
[7]
Catapano AL(2021)The backbone of treatment of dyslipidemia American J Intern Med 9 76-82
[8]
Graham I(2018)The prevalence, low-density lipoprotein cholesterol levels, and treatment of patients at very high risk of cardiovascular events in the United Kingdom: a cross-sectional study Curr Med Res Opin 34 1441-7
[9]
Backer GD(2019)Statin use and high-dose statin use after ischemic stroke in the UK: a retrospective cohort study Clin Epidemiol 2019 495-508
[10]
Wiklund O(2013)Discontinuation of statins in routine care settings: a cohort study Ann Intern Med 158 526-34